Biogenerics May Get Bounce As FDA Joins Debate; House Panel Eyes Bill

FDA will become an active participant this year in the debate over legislation creating a regulatory pathway for approval of generic biologics

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet